FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16169611000001107: Diprosalic scalp application (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57064301000001117 Diprosalic scalp application (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73227101000001116 Diprosalic 0.05%/2% scalp application (Lexon (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Diprosalic scalp application (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Is a Betamethasone+salicylic acid 0.05/3% scalp application false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has active ingredient Betamethasone true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Is a Diprosalic scalp false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Is a Diprosalic true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Is a Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application false Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) Is a Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Diprosalic scalp application (Lexon (UK) Ltd) 100 ml Has AMP True Diprosalic scalp application (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start